Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice

Abstract Background The recent development of biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) have expanded the possibilities of pharmacological treatment for patients with juvenile idiopathic arthritis (JIA). The objective of this study is to eval...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Hedda C. Lamers, Erika Van Nieuwenhove, Sebastiaan J. Vastert, Marc H. A. Jansen, Annet van Royen-Kerkhof, Joost F. Swart, Sytze de Roock
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-12-01
Schriftenreihe:	Pediatric Rheumatology Online Journal
Schlagworte:	Juvenile idiopathic arthritis Targeted therapies bDMARD Biologicals TsDMARDs CsDMARDs
Online-Zugang:	https://doi.org/10.1186/s12969-025-01173-5
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!